Header banner
Revain logoHome Page
Navruza Saitkulova photo
İstanbul
4 Level
306 Review
868.75 Karma

Review on FarmaTrust by Navruza Saitkulova

Revainrating 1 out of 5

It can be argued whether the project is alive or not anymore.

The project claims to be a platform that eliminates counterfeit medicines, provides efficiency in the pharmaceutical industry, and allows the purchase of original medicines anywhere and online. It planned to manage the system based on the blockchain and become more popular thanks to artificial intelligence and big data analysis. However, as we know, I think this project ended with failure like many projects that served in the market in the past.
The main reason I think this is because the FTT token has been removed from all the exchanges on which it is listed, and it seems impossible to buy anymore. So at least it is not traded on official and popular exchanges. For this reason, I don't think it would be any good to have this, because it's a completely worthless token.
I can say that the fact that the old website is not completed before the construction phase and the new website has a very meaningless and old design is not attractive and negatively affects the issue. In addition, I think that the suspension of a few links in the project also left many users like me in anxiety.
Finally, I see many negative aspects that are missing from the project. For this reason, I do not trust this anymore and I do not find it appropriate to invest



Pros
  • There are many things that seem negative
Cons
  • CMC's unmonitored list type
  • removed from the stock exchanges where it was listed
  • It caught the attention of very few investors
  • outdated design
  • his service was insufficient from the very beginning

Comments (1)

Please, sign in to write a comment
May 15, 2021
I investigated why the plan stopped the service. It is argued, in fact, that almost all users categorically refused to use it due to the staggering price of the token with some results. Naturally, because this is just a complaint, I have no clear idea.